A Dharwad firm Shilpa Biological Private Limited (SBPL), a wholly-owned subsidiary of Shilpa Medicare Limited has entered into a 3-year definitive agreement with Dr. Reddy’s Lab for Production and Supply for Sputnik V Vaccine from its integrated Biologics R&D cum Manufacturing Center at Dharwad.
‘The firm will produce 50 Million doses (both components 1&2) of the Dual Vector Sputnik V Vaccine for the first 12 months ‘ said Shilpa Medicare an exchange filing today.
As per the agreement, Shilpa Biologicals Private Limited will be responsible for the Manufacture of the vaccine, while Dr. Reddy’s Lab is responsible for the Distribution/Marketing of the vaccine.
The companies are also exploring the option to manufacture Sputnik Light, a single-dose version of the vaccine in near future, it added.
Shilpa Medicare added that it has set up a High end, Flexible Biologics facility in Dharwad to cater to the requirements of the fast-growing biologics field including Adenoviral subunit & DNA Vaccines, Monoclonal Antibodies & fusion proteins, etc.